Pluri Inc. (TLV:PLUR)

Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
1,518.00
-21.00 (-1.36%)
Oct 5, 2025, 3:49 PM IDT
-1.36%
Market Cap115.13M
Revenue (ttm)4.50M
Net Income (ttm)-76.09M
Shares Outn/a
EPS (ttm)-12.01
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume3,604
Average Volume3,310
Open1,502.00
Previous Close1,539.00
Day's Range1,502.00 - 1,575.00
52-Week Range1,299.00 - 2,345.00
Betan/a
RSI39.74
Earnings DateSep 12, 2025

About Pluri

Pluri Inc., a biotechnology company, engages in the research, development, and manufacture of cell-based products, cell therapeutics, and related technologies for various industries. It develops placenta-based cell therapy product candidates for the treatment of inflammatory, muscle injuries, and hematologic conditions; and immunotherapy platform. The company’s product candidates include PLX-PAD, that is composed of maternal mesenchymal stromal cells originating from the placenta for the treatment of various indications, such as acute muscle in... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2001
Employees 142
Stock Exchange Tel Aviv Stock Exchange
Ticker Symbol PLUR
Full Company Profile

Financial Performance

In 2025, Pluri's revenue was $1.34 million, an increase of 309.82% compared to the previous year's $326,000. Losses were -$22.58 million, 8.11% more than in 2024.

Financial numbers in USD Financial Statements

News

There is no news available yet.